Marina Picciotto, PhD, Charles B. G. Murphy Professor of Psychiatry and Professor in the Child Study Center, of Neuroscience and of Pharmacology, has been elected to the American College of Neuropsychopharmacology (ACNP) Council.
- April 09, 2021
Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled TrialSource: American Journal of Psychiatry
Yale Department of Psychiatry and Yale Child Study Center researchers conducted the first randomized placebo-controlled clinical trial of intravenous ketamine in adolescents with depression.
- April 05, 2021
Most reactions to the COVID-19 vaccines are minor, and severe reactions are very rare. But women experience side effects more often than men, a trend that does not surprise medical researchers.
- April 05, 2021Source: Haaretz
Dana Small, PhD, Professor of Psychiatry and Professor of Psychology, spoke to Haaretz about her research into the effects of processed food on the body and how the mind is impacted.
- March 26, 2021Source: WTVR 6 News Richmond
Some companies are laying out their plans to return to work in person. For example, Microsoft is giving employees in Seattle the option to return to the office starting next week.
- March 24, 2021
Researchers at Yale School of Medicine and the VA Connecticut Healthcare System, in a pair of complementary studies, investigated eating disorders in Iraq and Afghanistan war-era veterans, a group thought to be at high risk for the disorders.
- March 24, 2021
Surviving Violent, Traumatic Loss After Severe Political Persecution: Lessons From the Evaluation of a Venezuelan Asylum SeekerSource: BMJ Journals
Michelle Silva, PsyD, Assistant Professor of Psychiatry, is co-author of a case study in BMJ Journals that highlights the human rights violations occurring in Venezuela through the case of a Venezuelan woman who experienced political persecution and traumatic loss resulting from her opposition to the ruling socialist party.
- March 22, 2021Source: Medscape
Older patients recently diagnosed with dementia are at a significantly increased risk for suicide compared to their peers without dementia. Investigators found that individuals who were diagnosed with dementia had a 54% increased risk for suicide within the first year after diagnosis. The risk was particularly high among those aged 74 years and younger. Timothy Schmutte, PsyD, Assistant Professor of Psychiatry, was the study investigator.
- March 20, 2021Source: CNBC
When David Dudovitz ventured out to get his first dose of the Covid-19 vaccine last week, it was only the fourth time he had left his New York apartment since the pandemic began, and he wasn’t going to take any chances.
- March 17, 2021
Dr. Sarah Lichenstein is leading a study on how CBD may affect behavior and the brain to determine how it affects women and if it affects women and men differently.